Saleh Al-Abdulhadi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 13

Top Topics

Coronavirus Disease

Regulatory T Cells

Top Venues

Current oncology (Toronto, Ont.)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Manish Dhawan, Ali A Rabaan, Sara Alwarthan, Mashael Alhajri, Muhammad A Halwani, Amer Mohammad Alshengeti, Mustafa A Najim, Ameen S S Alwashmi, Ahmad A Alshehri, Saleh A Alshamrani, Bashayer M AlShehail, Mohammed Garout, Saleh Al-Abdulhadi, Shamsah H Al-Ahmed, Nanamika Thakur, Geetika Verma
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. Vaccines 11 (3) (2023)
Manish Dhawan, Ali A Rabaan, Sara Alwarthan, Mashael Alhajri, Muhammad A Halwani, Amer Mohammad Alshengeti, Mustafa A Najim, Ameen S S Alwashmi, Ahmad A Alshehri, Saleh A Alshamrani, Bashayer M AlShehail, Mohammed Garout, Saleh Al-Abdulhadi, Shamsah H Al-Ahmed, Nanamika Thakur, Geetika Verma
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. Vaccines 11 (3) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)
Ali A Rabaan, Muhammed A Bakhrebah, Hajir A Al Saihati, Saad Alhumaid, Roua A Alsubki, Safaa A Turkistani, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Ahlam A Alqatari, Hejji E Alahmed, Dalal A Sharbini, Arwa F Alahmadi, Fatimah Alsalman, Ahmed Alsayyah, Abbas Al Mutair
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers 14 (22) (2022)
Ali A Rabaan, Rehab Bukhamsin, Hajir A Al Saihati, Saleh A Alshamrani, Jehad AlSihati, Hani M Al-Afghani, Roua A Alsubki, Abdulmonem A Abuzaid, Saleh Al-Abdulhadi, Yahya Aldawood, Abdulmonem A Alsaleh, Yousef N Alhashem, Jenan A Almatouq, Talhah Bin Emran, Shamsah H Al-Ahmed, Firzan Nainu, Ranjan K Mohapatra
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland) 27 (24) (2022)